title: [CONTROLLING AN OUTBREAK OF RESPIRATORY SYNCYTIAL VIRUS (RSV AMONG NICU PATIENTS AND THE MEDICAL TEAM].
abstract: Respiratory Syncytial Virus (RSV is the most common cause of respiratory infections in infants, causing bronchiolitis and pneumonia. Premature infants have an increased risk for developing severe illness and even death. A monoclonal antibody vaccination named Palivizumab is available for preventing RSV infection. We describe an outbreak and control of RSV infections in one of our neonatal intensive care units, involving three patients and two medical team members.
authors.forename: Rachel
authors.initials: R
authors.lastname: Marans
authors.forename: Smadar
authors.initials: S
authors.lastname: Eventov-Friedman
authors.forename: Elite
authors.initials: E
authors.lastname: Cohen
authors.forename: Carmela
authors.initials: C
authors.lastname: Schwartz
authors.forename: Diana
authors.initials: D
authors.lastname: Averbukh
authors.forename: Benjamin
authors.initials: B
authors.lastname: Bar-Oz
mesh_terms: D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D007363:Intensive Care Units, Neonatal; D008297:Male; D000069455:Palivizumab / Q000008:administration & dosage; D010348:Patient Care Team; D018357:Respiratory Syncytial Virus Infections / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D000069455:Palivizumab